Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision entry v3.6.4 was added to the study history, replacing the previous revision v3.6.3. This updates the history record without modifying study data or results.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history gains a new revision entry v3.6.3, and the prior revision v3.6.2 is removed from the visible changes.SummaryDifference0.1%

- Check37 days agoChange DetectedThe history now includes a new revision entry v3.6.2, indicating a subsequent update to the record. The previous revision v3.6.0 is no longer listed in the history.SummaryDifference0.1%

- Check51 days agoChange DetectedThe study record now states 'No longer looking for participants', indicating recruitment is closed for this trial. The revision line shows 'Revision: v3.6.0' replacing the previous 'Revision: v3.5.5', signaling an updated version of the study record.SummaryDifference0.3%

- Check59 days agoChange DetectedA new site revision entry (v3.5.5) is added to the record history, replacing the previous revision (v3.5.4) and signaling an updated deployment of the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a newer software version has been applied to the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.